Skip to main content

Overview

The Machaca Lab is interested in the regulation of Ca²+ signaling pathways under both physiological and pathological conditions. Ca²+ signals are ubiquitous and are involved in a plethora of cell physiological processes including fertilization, cell proliferation, and gene expression. Our interest in the basic cellular and molecular mechanisms of Ca²+ signaling is framed in the context of several projects that the Lab is presently focused on.

We have a long standing interest in the regulation and remodeling of Ca²+ signaling pathways during the meiotic cell cycle. Before becoming fertilization competent oocytes undergo a maturation period - oocyte maturation - which encompasses entry into meiosis and dramatic remodeling of Ca²+ signaling pathways. This is a physiologically attractive model because a Ca²+ signal at fertilization is the universal trigger to induce egg activation in all sexually reproducing species tested to date. We are interested in the mechanisms mediating this molecular remodeling of Ca²+ signals during meiotic maturation. Such remodeling includes the IP3-dependent Ca²+ release, the plasma membrane Ca²+-ATPase at the cell membrane, and store- operated Ca²+ entry (see Figure). Ongoing projects in the Lab are focused on understanding the regulation of IP3-dependent Ca²+ release and store-operated Ca²+ entry (SOCE) during the meiotic cell cycle. This includes the basic molecular regulation of the two key molecules in SOCE, STIM1 and Orai1. STIM1 is the ER Ca²+ sensor that detects Ca²+ store depletion and activates the plasma membrane channel Orai1. We are further interested in the regulation of the IP3 receptor during hypertension in vascular smooth cells in a collaborative project with the Rusch Lab.

We are also interested in the regulation of the cell division phase by transition metals. We have discovered that transition metal chelation arrests the meiotic cell cycle through interfering with the function of the dual specificity phosphatase Cdc25C, a central player in the regulation of meiotic progression.

Highlights

  1. 1
    iScience · 2024
    PMID: 38510124PMCID: PMC10951641DOISenior author20 citations
  2. 2
    The Journal of cell biology · 2024
    PMID: 39499286PMCID: PMC11540855DOISenior author9 citations
  3. 3
    PLoS biology · 2020
    PMID: 33137110PMCID: PMC7660923DOISenior author18 citations

Publications

106 publications

Active

5 grants
  • KP
    Modulation of obesity and thermogenesis by intracellular calcium signalling
    Qatar National Research Fund · 2025–2028
    ARG02-0421-240243
  • PI
    Clinical personalized medicine to treat immunodeficiencies: Combining multiomics with functional characterization using cellular models to inform clinical treatment
    Qatar National Research Fund · 2024–2027
    PPM 06-0508-230025
  • Sub-PI
    Improving Diagnostic Yield in Genome-Negative Families with Multi-omics – Towards Personalized Medicine for Rare Disorders
    Qatar National Research Fund · 2024–2027 · via Sidra Medical and Research Center
    PPM 06-0507-230014
  • PI
    Regulation of inter-organelle membrane contact sites
    Qatar National Research Fund · 2024–2027
    ARG01-0517-230201
  • KP
    Unraveling the molecular mechanisms underlying the ability of PLC-zeta to trigger mammalian oocyte activation and early embryonic development
    Qatar National Research Fund · 2023–2026 · via Qatar University
    NPRP-BSRA01-0504-210082
Completed grants (6)
  • Co-I
    Targeting membrane progesterone receptors to improve insulin resistance
    Qatar National Research Fund · 2021–2024
    NPRP13S-0206-200274
  • PI
    Physiological association between diabetes mellitus and cardiac arrhythmia
    Qatar National Research Fund · 2020–2024
    NPRP12S-0212-190074
  • Sub-PI
    Unlocking precision medicine potential through functional genomic studies in the diagnosis of inherited immunodeficiency diseases
    Qatar National Research Fund · 2021–2023 · via Sidra Medical and Research Center
    PPM 04-0128-200015
  • PI
    Addgene 492139
    Addgene, Inc. · 2019–2020Contract
    Addgene 492139
  • PI
    Interplay Between Ca2+ Release and Ca2+ Entry Pathways in Hypertension-Induced Vascular Remodeling
    Qatar National Research Fund · 2016–2019
    NPRP 8-110-3-021
  • PI
    Regulation of Calcium Signaling during Oogenesis
    NIGMS · 2000–2011 · via NIH RePORTER
    R01GM061829-10

News mentions

External relationships

Advisory/Scientific Board Member

Aqur Biosciences INC · L'Oreal USA · ScieNFT

Other

Third Bridge